Authors/Disclosures
|
Gregory K. Bergey, MD, FAAN
|
Dr. Bergey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics. |
|
Riddhi Patira, MD
|
Dr. Patira has nothing to disclose. |
|
Gregory A. Worrell, MD
(Mayo Clinic College of Medicine)
|
Dr. Worrell has received stock or an ownership interest from NeuroOne Inc.. Dr. Worrell has received stock or an ownership interest from Cadence Neuroscience Inc. The institution of Dr. Worrell has received research support from NIH. The institution of Dr. Worrell has received research support from Medtronic Inc.. The institution of Dr. Worrell has received research support from Neuropace Inc,. The institution of Dr. Worrell has received research support from Epilepsy Foundation of America. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care. |
|
|
No disclosure on file |
|
Vidita Khatri, MD
|
No disclosure on file |
|
David R. Chabolla, MD
(Ascension Medical Group)
|
No disclosure on file |
|
Jeffrey Ruta, MD
|
Dr. Ruta has nothing to disclose. |
|
|
No disclosure on file |
|
Brian M. Sweis
|
No disclosure on file |
|
Camilo A. Gutierrez, MD, FAAN
(University of Maryland)
|
Dr. Gutierrez has received research support from American academy of Neurology. |
|
Douglas R. Labar, MD, PhD
(NY Presbyterian Weill Cornell Med Ctr K615)
|
No disclosure on file |
|
|
No disclosure on file |
|
Robert B. Duckrow, MD
(Yale University School of Medicine)
|
No disclosure on file |
|
Anthony M. Murro, MD
|
No disclosure on file |
|
Michael C. Smith, MD, FAAN
(Rush University Medical Center)
|
Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Lifesciences. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SK Lifesciences . |
|
David G. Vossler, MD, FAAN
(David G. Vossler MD FAAN FAES FACNS)
|
Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $0-$499 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Longboard Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. The institution of Dr. Vossler has received research support from SK Life Science. The institution of Dr. Vossler has received research support from Xenon Pharmaceuticals. The institution of Dr. Vossler has received research support from Longboard Pharmaceuticals. |
|
Gregory L. Barkley, MD
(Henry Ford Hospital)
|
No disclosure on file |
|
Martha Morrell, MD, FAAN
(NeuroPace/Stanford University)
|
Dr. Morrell has received personal compensation for serving as an employee of NeuroPace. Dr. Morrell has stock in NeuroPace. The institution of Dr. Morrell has received research support from National Institutes of Health. |